Ignite Creation Date:
2025-12-25 @ 4:43 AM
Ignite Modification Date:
2025-12-26 @ 3:44 AM
Study NCT ID:
NCT03850418
Status:
RECRUITING
Last Update Posted:
2025-02-10
First Post:
2019-02-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
Sponsor:
Henry Ford Health System
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-20
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-20
First Submit QC Date:
None
Study First Post Date:
2019-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-07
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL